SAN FRANCISCO, Aug. 20, 2026 /PRNewswire/ -- National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Following Capricor's recent Q2 2026 earnings release and conference call—notable for an omission of management Q&A...
Hence then, the article about capricor therapeutics inc capr investors september 28 2026 lead plaintiff deadline in class action lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit )
Also on site :
- Bessent’s $4 billion bond plan is like ‘rearranging deckchairs on the Titanic given the U.S. national debt of $40 trillion,’ ING says
- Walmart’s Rustic 5-Tier Bookcase Brimming With Farmhouse Charm Is Perfect for Book Lovers and Plant Parents
- 1990 No. 1 Garth Brooks Hit, Reimagined by a Rising Star, Ranked Among the ‘Greatest Country Songs of All Time’